Andrew Sinclair serves as Executive at SOLENO THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Andrew Sinclair has executed 14 insider transactions totaling $33.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 6, 2024 involved receiving (via award) 6,500 shares valued at $0.
Andrew Sinclair currently holds 6,500 shares of SOLENO THERAPEUTICS INC (SLNO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Sinclair has been a net buyer of SLNO stock. They have purchased $33.8M and sold $0 worth of shares.
Andrew Sinclair's most recent insider trade was on Jun 6, 2024, when they sold 6,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 1, 2023 | ACET | $0 | Award | 5,900 | $N/A | Discretionary |
| Jul 1, 2022 | SRRA | $72.3M | Disposition | 1,314,127 | $55.00 | Discretionary |
| Mar 29, 2022 | SLNO | $0 | Purchase | 7,720,000 | $N/A | Discretionary |
| Jan 31, 2022 | SRRA | $4.0M | Purchase | 150,000 | $27.00 | Discretionary |
| Jan 28, 2022 | SRRA | $3.8M | Exercise | 287,471 | $13.20 | Discretionary |
| Dec 8, 2021 | ACET | $7.0M | Purchase | 500,000 | $14.00 | Discretionary |
| Dec 8, 2021 | ACET | $7.0M | Purchase | 500,000 | $14.00 | Discretionary |
| Jun 26, 2020 | SLNO | $5.5M | Purchase | 3,333,330 | $1.65 | Discretionary |
| Jan 29, 2020 | SRRA | $0 | Conversion | 871,125 | $N/A | Discretionary |
| Jan 29, 2020 | SRRA | $0 | Conversion | 871,240 | $N/A | Discretionary |
| Oct 25, 2019 | SLNO | $2.8M | Purchase | 2,300,000 | $1.20 | Discretionary |
| Dec 21, 2018 | SLNO | $7.5M | Purchase | 4,669,272 | $1.60 | Discretionary |